ArticleChina CDC weekly2026
Analysis of Spatiotemporal Variation Characteristics and Influencing Factors of Human Brucellosis - Shaanxi Province, China, 2015-2024.
Article in China CDC weekly, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
What is already known about this topic?: Human brucellosis poses a serious threat to the health of residents in Shaanxi Province, China. What is added by this report?: Between 2015 and 2024, the annual incidence rate of human brucellosis in Shaanxi, China, remained at historically high levels, exhibiting a high-to-low gradient from north to south, and its influencing factors demonstrated spatiotemporal heterogeneity. What are the implications for public health practice?: Targeted surveillance and control strategies for human brucellosis should be implemented according to local epidemiological characteristics. Surveillance and early warning capacity in the high-risk areas must be strengthened, and differentiated prevention and control measures should be developed accordingly.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.